Skip to content

Author

G. Gandaglia

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Real-world Data to Assess the Applicability of Randomized Controlled Trials in Newly Metastatic Prostate Cancer.

BACKGROUND Concerns persist regarding the applicability of randomized controlled trials (RCTs) on metastatic hormone-sensitive prostate cancer (mHSPC) to real-world clinical practice. OBJECTIVE We aimed to evaluate the generalizability of RCTs using data from PIONEER. DESIGN, SETTING AND PARTICIPANTS Trial eligibil...

G. Gandaglia, F. Pellegrino, A. Hijazy et al. · 0 citations
Sep 2026

Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with cryotherapy vs. external beam radiation therapy

Population-based observations indicate that cryotherapy is associated with a higher risk of CSM compared with EBRT in these patients, and univariable competing risks regression models tested for CSM differences after accounting for other-cause mortality (OCM) as a competing event.

L. Quarta, M. Petix, M. Filzmayer et al. · 0 citations
Review Sep 2026

Stage migration in prostate cancer: the role of PSMA-PET in identifying oligometastatic disease

Compared with CI, PSMA-PET detected more patients with de novo oligometastatic and multimetastatic disease and produced stage migration in intermediate- to high-risk patients and were associated with changes in the intended treatment plan.

F. Mattana, S. Luzzago, V. Dragonetti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.